Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment
Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout
Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
Double-Blind Study of Miglitol in Japanese With type2 Diabetes
Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)